Internal Medicine, Critical Care Medicine · Bordentown, NJ
NPI
1336195056
Since 2006
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6500 Kevin Johnson Blvd, Suite 100b
Bordentown, NJ, 08505
Phone (609) 444-5404
Groups this clinician bills Medicare through
Medicare paid, 2024
$205K
2,322 services
Medicare patients, 2024
768
Average age 74
Drug cost, 2024
$1.8M
5,677 prescriptions
Company payments, 2025
$1,380
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marc M Seelagy was code 99233 (hospital e&m - subsequent), 694 times for 191 patients. In total Marc M Seelagy billed 2,322 services in 28 codes, and Medicare paid $205K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 694 | 191 | $98.15 | $68K |
| 99214 Office E&M - Established | Office | 521 | 329 | $101.21 | $53K |
| 99232 Hospital E&M - Subsequent | Facility | 286 | 80 | $65.11 | $19K |
| 99213 Office E&M - Established | Office | 161 | 138 | $66.70 | $11K |
| 99223 Hospital E&M - Initial | Facility | 118 | 112 | $142.21 | $17K |
| 94729 Pulmonary Function Testing | Office | 98 | 97 | $48.91 | $4,793 |
| 99204 Office E&M - New | Office | 61 | 61 | $132.59 | $8,088 |
| 94726 Pulmonary Function Testing | Office | 59 | 59 | $48.06 | $2,835 |
| 99291 Critical Care E&M | Facility | 50 | 31 | $175.96 | $8,798 |
| 94010 Pulmonary Function Testing | Office | 50 | 49 | $23.39 | $1,170 |
| 94060 Pulmonary Function Testing | Office | 48 | 48 | $33.69 | $1,617 |
| 94727 Pulmonary Function Testing | Office | 39 | 39 | $38.52 | $1,502 |
| 95800 Sleep Study | Office | 33 | 33 | $33.98 | $1,121 |
| 95806 Sleep Study | Office | 27 | 27 | $37.69 | $1,018 |
| 99215 Office E&M - Established | Office | 14 | 13 | $153.17 | $2,144 |
By year: 2022 $244K for 2,681 services; 2023 $161K for 1,833 services; 2024 $205K for 2,322 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marc M Seelagy prescribed most often to Medicare patients was Montelukast Sodium, with 979 prescriptions and refills. In total Marc M Seelagy wrote 5,677 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 979 | 2,217 | 278 | $13K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 650 | 1,112 | 153 | $692K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 496 | 775 | 194 | $28K |
| Breo Ellipta Fluticasone/Vilanterol | 446 | 633 | 122 | $237K |
| Azelastine Hcl Generic | 321 | 563 | 121 | $9,925 |
| Fluticasone Propionate Generic | 279 | 520 | 103 | $4,765 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 268 | 415 | 84 | $49K |
| Prednisone Generic | 193 | 251 | 118 | $673 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 187 | 285 | 56 | $172K |
| Azelastine-Fluticasone Azelastine/Fluticasone | 186 | 264 | 80 | $26K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 167 | 255 | 34 | $109K |
| Spiriva Respimat Tiotropium Bromide | 123 | 187 | 30 | $93K |
| Incruse Ellipta Umeclidinium Bromide | 84 | 115 | 18 | $38K |
| Roflumilast Generic | 83 | 145 | 20 | $5,935 |
| Ipratropium Bromide Generic | 82 | 124 | 18 | $1,702 |
Brand drugs: 2,572 claims; generic drugs: 3,105 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marc M Seelagy $1,380 ($1,380 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $484.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 22 | $484 |
| GlaxoSmithKline, LLC. GSK | 23 | $270 |
| Insmed, Inc. INSM | 5 | $84.42 |
| Amgen Inc. AMGN | 5 | $83.97 |
| Viatris Specialty LLC | 4 | $76.36 |
| Grifols USA, LLC | 3 | $67.12 |
| Harmony Biosciences LLC HRMY | 3 | $49.54 |
| Inspire Medical Systems, Inc. INSP | 2 | $38.81 |
| Axsome Therapeutics, Inc. AXSM | 2 | $36.93 |
| Genzyme Corporation SNY | 2 | $35.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.